AgomAb Therapeutics NV Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EQT FUND MANAGEMENT S.A R.L. | 08/13/2026 | 5.14 M | $66.74 M | 0.00% | 10.55% |
| SANOFI | 07/28/2026 | 2.78 M | $36.12 M | 0.00% | 5.71% |
| REDMILE GROUP, LLC | 08/14/2026 | 2.73 M | $35.49 M | 1,649.71% | 5.61% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2026 | 2.47 M | $32.00 M | 0.00% | 5.06% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 2.05 M | $26.65 M | 0.00% | 4.21% |
| FEDERATED HERMES, INC. | 08/12/2026 | 1.62 M | $21.00 M | 0.00% | 3.32% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 1.57 M | $20.36 M | 30.68% | 3.22% |
| CASDIN CAPITAL, LLC | 08/14/2026 | 1.55 M | $20.12 M | 0.00% | 3.18% |
| ANDERA PARTNERS | 07/22/2026 | 1.54 M | $19.97 M | 0.00% | 3.16% |
| FMR LLC | 08/13/2026 | 1.46 M | $18.93 M | 0.00% | 2.99% |
| ABRDN PLC | 07/31/2026 | 846.70 K | $10.99 M | 19.65% | 1.74% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 600.00 K | $7.79 M | 0.00% | 1.23% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2026 | 600.00 K | $7.79 M | 0.00% | 1.23% |
| SIREN, L.L.C. | 08/13/2026 | 411.25 K | $5.34 M | 0.00% | 0.84% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 192.74 K | $2.50 M | 100.00% | 0.40% |
| PFIZER INC | 08/13/2026 | 75.00 K | $1.04 M | 0.00% | 0.15% |
| ALPS ADVISORS INC | 07/29/2026 | 49.98 K | $648.79 K | 100.00% | 0.10% |
| BELLEVUE GROUP AG | 08/14/2026 | 49.25 K | $639.24 K | -1.50% | 0.10% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 47.60 K | $617.85 K | -76.20% | 0.10% |
| SECTORAL ASSET MANAGEMENT INC | 08/14/2026 | 43.50 K | $564.63 K | 0.00% | 0.09% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 35.00 K | $454.30 K | 0.00% | 0.07% |
| QUADRATURE CAPITAL LTD | 08/07/2026 | 20.46 K | $265.58 K | 100.00% | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 18.07 K | $234.58 K | 26.90% | 0.04% |
| HRT FINANCIAL LP | 08/14/2026 | 17.08 K | $221.00 K | -28.03% | 0.04% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 11.80 K | $153.16 K | -66.98% | 0.02% |
| XTX TOPCO LTD | 08/14/2026 | 10.27 K | $133.32 K | 100.00% | 0.02% |
| CITIGROUP INC | 08/03/2026 | 9.50 K | $123.26 K | 100.00% | 0.02% |
| UBS GROUP AG | 08/13/2026 | 2.13 K | $27.62 K | -66.94% | 0.00% |
| GAMMA INVESTING LLC | 07/07/2026 | 1.34 K | $17.45 K | 100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 1.20 K | $15.58 K | -60.33% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 754 | $9.79 K | 100.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 08/14/2026 | 698 | $9.06 K | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 2 | $26 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 2 | $26 | 100.00% | 0.00% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| LAURION CAPITAL MANAGEMENT LP | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 09/02/2026 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| LMR PARTNERS LLP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AgomAb Therapeutics NV institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of AgomAb Therapeutics NV. The most heavily invested institutionals were:
EQT Fund Management S.a r.l.: 5.14 M
Sanofi: 2.78 M
Redmile Group, LLC: 2.73 M
Cormorant Asset Management, LP: 2.47 M
TCG Crossover Management, LLC: 2.05 M
FEDERATED HERMES, INC.: 1.62 M
53.26% of AgomAb Therapeutics NV stock is owned by institutional investors.
Institutional investors have bought a total of 25.96 M shares in the last 24 months. This purchase volume represents approximately $374.54 M in transactions.